Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 8,409 shares of the company’s stock in a transaction dated Monday, December 4th. The shares were purchased at an average cost of $5.48 per share, for a total transaction of $46,081.32. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, November 29th, Levin Capital Strategies, L.P. purchased 20,380 shares of Fluidigm stock. The shares were purchased at an average cost of $5.71 per share, for a total transaction of $116,369.80.
  • On Friday, November 17th, Levin Capital Strategies, L.P. purchased 6,880 shares of Fluidigm stock. The shares were purchased at an average cost of $5.05 per share, for a total transaction of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. purchased 54,900 shares of Fluidigm stock. The shares were purchased at an average cost of $5.26 per share, for a total transaction of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. purchased 4,227 shares of Fluidigm stock. The shares were purchased at an average cost of $5.42 per share, for a total transaction of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. purchased 22,363 shares of Fluidigm stock. The shares were purchased at an average cost of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm stock. The shares were purchased at an average cost of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. purchased 144,200 shares of Fluidigm stock. The shares were purchased at an average cost of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. purchased 50,000 shares of Fluidigm stock. The shares were purchased at an average cost of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm stock. The shares were purchased at an average cost of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm stock. The shares were purchased at an average cost of $5.25 per share, for a total transaction of $315,000.00.

Fluidigm Co. (NASDAQ:FLDM) traded up $0.24 during trading hours on Wednesday, hitting $5.70. The company had a trading volume of 141,900 shares, compared to its average volume of 256,891. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02. Fluidigm Co. has a 12 month low of $2.52 and a 12 month high of $8.69.

Several large investors have recently added to or reduced their stakes in FLDM. American International Group Inc. raised its stake in shares of Fluidigm by 7.1% during the 1st quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock valued at $102,000 after purchasing an additional 1,187 shares during the period. Virtu KCG Holdings LLC bought a new stake in shares of Fluidigm during the 2nd quarter valued at $105,000. Sei Investments Co. raised its stake in shares of Fluidigm by 221.7% during the 3rd quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 14,932 shares during the period. PDT Partners LLC raised its stake in shares of Fluidigm by 56.0% during the 2nd quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 9,800 shares during the period. Finally, Group One Trading L.P. raised its stake in shares of Fluidigm by 336.9% during the 3rd quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 17,855 shares during the period. Institutional investors own 93.33% of the company’s stock.

Separately, ValuEngine cut Fluidigm from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th.

ILLEGAL ACTIVITY WARNING: “Insider Buying: Fluidigm Co. (FLDM) Insider Buys 8,409 Shares of Stock” was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://theolympiareport.com/2017/12/06/insider-buying-fluidigm-co-fldm-insider-buys-8409-shares-of-stock.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.